Is Another Heparin Crisis Looming? Congress Raises Alarm, Demands US FDA Briefing
The FDA must explain how it will prevent heparin adulteration as a virus kills pigs in China again.
You may also be interested in...
Fewer inspections but more warning letters, import alerts and drug-shortage discretions were seen as office sought to ameliorate COVID-19 impacts.
Crude heparin supplier Yibin Lihao headlines list of facilities in 12 countries added to the US FDA’s drug GMP import alert.
US House committee requests FDA commissioner to provide a contingency response plan should pressures on China's heparin supply chain trigger more of the economically motivated adulteration that killed scores of US patients in 2008.